145 related articles for article (PubMed ID: 26117091)
1. Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
Whale R; Fialho R; Rolt M; Eccles J; Pereira M; Keller M; File A; Haq I; Tibble J
J Psychosom Res; 2015 Dec; 79(6):640-5. PubMed ID: 26117091
[TBL] [Abstract][Full Text] [Related]
2. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
Mahajan S; Avasthi A; Grover S; Chawla YK
J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
[TBL] [Abstract][Full Text] [Related]
3. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
4. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
Neri S; Pulvirenti D; Bertino G
Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
[TBL] [Abstract][Full Text] [Related]
6. De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.
Martín-Santos R; Díez-Quevedo C; Castellví P; Navinés R; Miquel M; Masnou H; Soler A; Ardevol M; García F; Galeras JA; Planas R; Solà R
Aliment Pharmacol Ther; 2008 Feb; 27(3):257-65. PubMed ID: 17988237
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Udina M; Moreno-España J; Navinés R; Giménez D; Langohr K; Gratacòs M; Capuron L; de la Torre R; Solà R; Martín-Santos R
Psychoneuroendocrinology; 2013 Sep; 38(9):1803-13. PubMed ID: 23571152
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J; Karila L; Costisella O; Canva V
Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska.
Banjac V; Zivlak-Radulovic N; Miskovic M
Med Arch; 2016 Apr; 70(2):127-30. PubMed ID: 27147788
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.
Udina M; Castellví P; Moreno-España J; Navinés R; Valdés M; Forns X; Langohr K; Solà R; Vieta E; Martín-Santos R
J Clin Psychiatry; 2012 Aug; 73(8):1128-38. PubMed ID: 22967776
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
Fialho R; Burridge A; Pereira M; Keller M; File A; Tibble J; Whale R
Psychopharmacology (Berl); 2016 May; 233(9):1689-94. PubMed ID: 25971875
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
Schaefer M; Hinzpeter A; Mohmand A; Janssen G; Pich M; Schwaiger M; Sarkar R; Friebe A; Heinz A; Kluschke M; Ziemer M; Gutsche J; Weich V; Halangk J; Berg T
Hepatology; 2007 Oct; 46(4):991-8. PubMed ID: 17668880
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients.
Arase Y; Suzuki Y; Suzuki F; Matsumoto N; Akuta N; Imai N; Seko Y; Sezaki H; Kawamura Y; Kobayashi M; Hosaka T; Saito S; Ikeda K; Kobayashi M; Kumada H
Intern Med; 2011; 50(19):2083-8. PubMed ID: 21963723
[TBL] [Abstract][Full Text] [Related]
15. Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality.
Castellvi P; Navinés R; Gutierrez F; Jiménez D; Márquez C; Subirà S; Solà R; Martín-Santos R
J Clin Psychiatry; 2009 Jun; 70(6):817-28. PubMed ID: 19573480
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks.
Robaeys G; De Bie J; Wichers MC; Bruckers L; Nevens F; Michielsen P; Van Ranst M; Buntinx F
World J Gastroenterol; 2007 Nov; 13(43):5736-40. PubMed ID: 17963300
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
Reichenberg A; Gorman JM; Dieterich DT
AIDS; 2005 Oct; 19 Suppl 3():S174-8. PubMed ID: 16251815
[TBL] [Abstract][Full Text] [Related]
18. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
Quarantini LC; Bressan RA; Galvão A; Batista-Neves S; Paraná R; Miranda-Scippa A
Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
[TBL] [Abstract][Full Text] [Related]
19. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.
Dell'Osso L; Pini S; Maggi L; Rucci P; Del Debbio A; Carlini M; Baldini A; Ferrari G; Manca E; Beverini E; Amore M; Scarallo V; Semeraro Q; Brunetto M; Bonino F; Maj M
J Psychosom Res; 2007 Mar; 62(3):349-55. PubMed ID: 17324686
[TBL] [Abstract][Full Text] [Related]
20. Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.
Saadoun D; Resche Rigon M; Thibault V; Longuet M; Pol S; Blanc F; Pialoux G; Karras A; Bazin-Karra D; Cazorla C; Vittecoq D; Musset L; Decaux O; Ziza JM; Lambotte O; Cacoub P
Ann Rheum Dis; 2014 May; 73(5):831-7. PubMed ID: 23606708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
